117 related articles for article (PubMed ID: 37003027)
1. Economic assessment of childhood rotavirus vaccination in Bangladesh.
Sarker AR
J Infect Public Health; 2023 May; 16(5):816-822. PubMed ID: 37003027
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of introducing universal childhood rotavirus vaccination in Bangladesh.
Sarker AR; Sultana M; Mahumud RA; Van Der Meer R; Morton A
Hum Vaccin Immunother; 2018 Jan; 14(1):189-198. PubMed ID: 29099653
[TBL] [Abstract][Full Text] [Related]
3. Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines.
Pecenka C; Debellut F; Bar-Zeev N; Anwari P; Nonvignon J; Shamsuzzaman M; Clark A
Vaccine; 2018 Nov; 36(49):7472-7478. PubMed ID: 30420039
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness and budget impact analyses for the prioritisation of the four available rotavirus vaccines in the national immunisation programme in Thailand.
Luangasanatip N; Mahikul W; Poovorawan K; Cooper BS; Lubell Y; White LJ; Teerawattananon Y; Pan-Ngum W
Vaccine; 2021 Mar; 39(9):1402-1414. PubMed ID: 33531197
[TBL] [Abstract][Full Text] [Related]
5. Economic analysis for national immunization program planning: A case of rotavirus vaccines in Burundi.
Niyibitegeka F; Riewpaiboon A; Youngkong S; Thavorncharoensap M
Vaccine; 2021 Feb; 39(8):1272-1282. PubMed ID: 33487467
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of rotavirus vaccination in Mozambique.
Lourenço Guimarães E; Chissaque A; Pecenka C; Clark A; Vaz B; Banze A; Canana N; Romão C; do Rosário Oliveira Martins M; de Deus N; Debellut F
Vaccine; 2022 Aug; 40(36):5338-5346. PubMed ID: 35933279
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of rotavirus vaccination in the Philippines: A modeling study.
Villanueva-Uy MET; Lam HY; Aldaba JG; Uy TMZ; Valverde HA; Silva MWT; Mooney J; Clark A; Pecenka C
Vaccine; 2021 Nov; 39(48):7091-7100. PubMed ID: 34753614
[TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of rotavirus vaccination in children of Bhutan.
Pempa ; Luz ACG; Luangasanatip N; Kingkaew P; Adhikari D; Isaranuwatchai W; Choiphel D; Pecenka C; Debellut F
Vaccine; 2020 Jul; 38(32):5049-5059. PubMed ID: 32522415
[TBL] [Abstract][Full Text] [Related]
9. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
Bergman H; Henschke N; Hungerford D; Pitan F; Ndwandwe D; Cunliffe N; Soares-Weiser K
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD008521. PubMed ID: 34788488
[TBL] [Abstract][Full Text] [Related]
10. Impact and cost-effectiveness of rotavirus vaccination in Niger: a modelling study evaluating alternative rotavirus vaccines.
Debellut F; Tang K; Clark A; Pecenka C; Assao B; Guindo O; Grais RF; Isanaka S
BMJ Open; 2022 Oct; 12(10):e061673. PubMed ID: 36198460
[TBL] [Abstract][Full Text] [Related]
11. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
Soares-Weiser K; Bergman H; Henschke N; Pitan F; Cunliffe N
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684685
[TBL] [Abstract][Full Text] [Related]
12. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
Soares-Weiser K; Bergman H; Henschke N; Pitan F; Cunliffe N
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD008521. PubMed ID: 30912133
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of a rotavirus immunization program for the United States.
Tucker AW; Haddix AC; Bresee JS; Holman RC; Parashar UD; Glass RI
JAMA; 1998 May; 279(17):1371-6. PubMed ID: 9582045
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of the introduction of rotavirus vaccine in Hong Kong.
Yeung KHT; Lin SL; Clark A; McGhee SM; Janusz CB; Atherly D; Chan KC; Nelson EAS
Vaccine; 2021 Jan; 39(1):45-58. PubMed ID: 33221066
[TBL] [Abstract][Full Text] [Related]
15. Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.
Tu HA; Rozenbaum MH; Coyte PC; Li SC; Woerdenbag HJ; Postma MJ
Vaccine; 2012 Feb; 30(8):1521-8. PubMed ID: 22119590
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model.
Patel HD; Roberts ET; Constenla DO
Vaccine; 2013 Dec; 31(51):6072-8. PubMed ID: 24176497
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran.
Javanbakht M; Moradi-Lakeh M; Yaghoubi M; Esteghamati A; Mansour Ghanaie R; Mahmoudi S; Shamshiri AR; Zahraei SM; Baxter L; Shakerian S; Chaudhri I; Fleming JA; Munier A; Baradaran HR
Vaccine; 2015 May; 33 Suppl 1():A192-200. PubMed ID: 25919160
[TBL] [Abstract][Full Text] [Related]
18. Updated cost-effectiveness and risk-benefit analysis of two infant rotavirus vaccination strategies in a high-income, low-endemic setting.
Bruijning-Verhagen P; van Dongen JAP; Verberk JDM; Pijnacker R; van Gaalen RD; Klinkenberg D; de Melker HE; Mangen MJ
BMC Med; 2018 Sep; 16(1):168. PubMed ID: 30196794
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness estimates of vaccination against rotavirus in Piedmont, Italy.
Gualano MR; Thomas R; Gili R; Scaioli G; Voglino G; Zotti C
J Infect Public Health; 2018; 11(6):867-872. PubMed ID: 30078657
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of rotavirus vaccination in China: Projected possibility of scale-up from the current domestic option.
Cui S; Tobe RG; Mo X; Liu X; Xu L; Li S
BMC Infect Dis; 2016 Nov; 16(1):677. PubMed ID: 27846803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
